Company Number: 14125063

Analysis Date: 2025-07-20 15:30 UTC

Financial Health Assessment for SIMDYCATE LIMITED

---

1. Financial Health Score: D

Explanation:
The company is currently dormant with minimal financial activity and negative net assets. The absence of operating revenues or assets coupled with liabilities, though nominal, indicates a fragile financial state. While not in immediate distress, these "symptoms" suggest a need for active management to avoid deterioration.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	0	No long-term investments or tangible resources held.
Current Assets	0	No cash, receivables, or stock to support operations.
Current Liabilities	27	Small short-term debts present despite dormancy.
Net Current Assets	-27	Negative working capital, unable to cover short-term debts.
Total Assets less Current Liabilities	-26	Overall net liabilities indicate a balance sheet deficit.
Net Assets / Shareholders Funds	-26	Negative equity, shareholders' funds are in deficit.
Employee Count	0	No employees; no operational activity.
Account Category	Dormant	Company has not traded during the financial year.

Interpretation:
The "vital signs" show SIMDYCATE LIMITED is a dormant entity with no operational assets or revenues and minor liabilities. The negative net asset position, though small (£26), reflects a technical insolvency on paper but not significant enough to indicate immediate financial distress. The lack of employees and nil current assets signal no active business operations.

---

3. Diagnosis

SIMDYCATE LIMITED is currently in a state of financial hibernation, similar to a patient in remission without active symptoms but with underlying weakness. The company has filed dormant accounts as per regulatory requirements, showing no trading activity or revenue generation. The nominal liabilities and negative net assets are small but indicate that the company has some outstanding obligations likely related to company formation or minimal administrative expenses.

This "lack of financial pulse" means the company is neither generating cash flow nor incurring significant costs, which is typical of dormant companies. However, the negative equity position, while marginal, suggests that if the company were to start trading without capital infusion or revenue, it could quickly face financial strain.

---

4. Recommendations

• Capital Injection or Asset Acquisition: To move from dormancy to active trading, the company will need fresh capital or acquisition of fixed/current assets to establish a healthy cash flow.

• Liability Management: Address the current liabilities of £27 to clear the negative working capital "infection" and prevent accumulation of overdue debts.

• Business Activation Plan: Develop a strategic plan to commence trading aligned with the SIC codes (software development). This includes market research, product development, and budgeting for operational expenses.

• Regular Financial Monitoring: Once active, implement monthly cash flow monitoring and maintain positive working capital to ensure a "healthy financial pulse."

• Compliance Maintenance: Continue timely filing of accounts and confirmation statements to avoid regulatory "penalties" which can exacerbate financial distress.

• Consider Liquidation if Inactive Long-Term: If there is no intention to trade, consider formal dissolution to prevent ongoing administrative costs and liabilities.

---